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Abstract:  In this review, we focus on processes, organs and systems targeted by the 
marine toxins yessotoxin (YTX), okadaic acid (OA) and palytoxin (PTX). The effects of 
YTX and their basis are analyzed from data collected in the mollusc Mytilus 
galloprovincialis, the annelid Enchytraeus crypticus, Swiss CD1 mice and invertebrate and 
vertebrate cell cultures. OA and PTX, two toxins with a better established mode of action, 
are analyzed with regard to their effects on development. The amphibian Xenopus laevis is 
used as a model, and the Frog Embryo Teratogenesis Assay-Xenopus (FETAX) as the 
experimental protocol. 
Keywords: development; FETAX; marine toxins; invertebrate; vertebrate; cell cultures; 
toxin targets 
 
1. Introduction 
The studies and reviews on the marine toxins are becoming more numerous due to the increase in 
the frequency and the distribution in many regions of the world of algal toxins that can damage public 
health, fishing, fish and shellfish cultures, and marine ecosystems. In particular, it has been reported 
that algal toxins are responsible for more than 50,000–500,000 intoxication incidents in humans per 
year, with an overall mortality rate of 1.5% on a global basis [1]. Furthermore, toxic algae are also 
responsible for the death of animals dependent on the marine food web [2–5]. The human ingestion of 
contaminated marine organisms provokes pathological symptoms that were collectively labeled more 
than 40 years ago with the term biopoisonings [6]. Among the approximately 5,000 marine algal 
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species, less than 100, mainly from the dinoflagellates and diatoms taxa, produce toxins [7]. The 
increasing presence of algal toxins determined by various known (water ballast from merchant ships, 
eutrophication of the coastal areas, anthropogenic eutrophication, etc.) and unknown agents has been 
called “harmful algal bloom” [8,9]. Algal toxins may be classified by function of their target and 
seafood poisoning syndromes [1]. 
Here we report the findings from our and other groups on the marine toxins yessotoxin (YTX), 
okadaic acid (OA) and palytoxin (PTX). However, since toxicological properties of YTX and the 
molecular targets of OA and PTX have already been exhaustively reviewed [10–14], we will focus our 
analysis on the possible mechanisms of action and target organs for YTX and will summarize the 
effects that OA and PTX exert on vertebrate embryos and their development. We describe experiments 
that have studied YTX effects on mussels, mice and both invertebrate and vertebrate cell cultures, in 
order to isolate possible biological targets of YTX at both organ and cellular level. For PTX and OA, 
we report experiments performed either on invertebrates or using the amphibian Xenopus laevis as a 
model and the Frog Embryo Teratogenesis Assay-Xenopus (FETAX) as the experimental protocol. 
2. Yessotoxin (YTX) 
2.1. General proprieties 
YTX is a sulfated polyether compound originally isolated in Japan from the digestive gland of the 
scallop  Patinopecten yessoensis [15], and is produced by phytoplanktonic microalgae of some 
dinoflagellate species. As they were extracted together with toxins provoking clinical symptoms of 
diarrheic shellfish poisoning (DSP), YTX and its derivatives were originally classified among 
diarrheic shellfish toxins (DSTs). However, unlike the latter, YTXs do not provoke diarrhea and are 
not lethal to mice after oral intake even at a dose of 1 mg/kg [16]. Nevertheless, the precise mode of 
action remains currently unknown, even if YTX seems to be a potent phosphodiesterase activator [17]. 
The toxicological data from studies carried out in rodents are conflicting, in particular regarding the 
lethal dose concentration after intraperitoneal injection, which ranged from 80–1,000 μg/kg [16,18–20]. 
The main internal organs examined after mice death did not show any significant histomorphological 
changes clearly related to the toxin [16], while the main target organ after acute or daily repeated oral 
administration has been long reported to be the heart tissue [14,16,18,20]. Despite these somehow 
discrepant observations, evidence of YTX action on neuronal cells, which are vulnerable biological 
targets, has also been reported. Death of animals during mouse experiments was preceded by 
symptoms that included motor discoordination and jumping, while cerebellar cortical alterations were 
also demonstrated [21,22]. Several in vitro studies have been performed in order to elucidate the 
mechanism(s) of action and the possible target of YTX at cellular level. These experiments have 
confirmed the results of morphological analyses and suggest a high cytotoxicity for YTX affecting a 
variety of cellular activities. YTX has been seen to promote the activity of caspases 3 and 7 in HeLa 
cells [23], it opens the permeability transition pore in rat liver mitochondria [24] and causes 
cytoskeletal disruption together with apoptosis in cultured cerebellar neurons [25]. Very recently, the 
effects of YTX on cytoskeletal components of vertebrate cells has been connected with a reduced 
phagocytic activity and the inhibition of phagosome maturation in the J774 macrophage cell line [26]. 
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2.2. Data derived from experiments on invertebrate and vertebrate cell lines 
Although several reports have confirmed the cytotoxic potentialities of YTX, it has remained a 
highly interesting but scattered scenario, as the primitive target of YTX remains unclear [27]. In this 
perspective, we performed experiments testing an insect and a mammalian cell line in parallel. The 
effects of 10 and 100 nM YTX on the IPLB-LdFB insect cell line, derived from the larval fat body of 
the gypsy moth Lymantria dispar [28,29], were compared with those on the mouse fibroblast NIH3T3 
cell line [30]. The experiments confirmed that YTX displays a concentration-dependent and   
cell-specific cytotoxic activity. These findings also demonstrated that in both IPLB-LdFB and NIH3T3 
cells, F-actin microfilaments are progressively depolymerized within 48 h after the exposure to YTX 
(Figure 1). Moreover, by using a combination of morphological markers for acidic compartments, it 
was possible to demonstrate that in both the cell types, the lysosomal content moved quickly into the 
cytoplasm, thus indicating that lysosomes may be the first cellular component damaged by YTX 
(Figure 2) [30]. In our hypothesis, the documented increase in Ca
2+ concentration that follows YTX 
exposure in different cell types [14,31,32] could promote the spilling of lysosomal content into the 
cytoplasm, in turn promoting all the other well established processes, such as actin depolymerization.  
Figure 1. Time-dependent depolymerization of F-actin promoted by YTX in IPLB-LdFB 
and NIH3T3 cell lines evidenced by FITC-phalloidin labeling and DAPI nuclear 
counterstaining. IPLB-LdFB: control cells (A); and IPLB-LdFB after 24 h (B), 48 h (C) 
and 72 h (D) incubation with 100 nM YTX; NIH3T3 control cells (E); and NIH3T3 cells 
after 24 h (F); 48 h (G); 72 h (H) incubation with 100 nM YTX. Bar = 10 μm. (Reprinted 
with permission from [30]). 
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Figure 2. Lysosomal damage promoted by YTX in IPLB-LdFB cell lines evidenced by 
neutral red (A–D), acridine orange (E–H) and acid phosphatase activity (I–N) methods. A, 
E, I) IPLB-LdFB control cells; B, F, L) IPLB-LdFB cells after 8 h incubation with 100 nM 
YTX; C, G, M) IPLB-LdFB cells after 12 h incubation with 100 nM YTX; D, H, N)  
IPLB-LdFB cells after 24 h incubation with 100 nM YTX. Bar = 10 μm. (Reprinted with 
permission from [30]). 
 
2.3. Data derived from experiments on the mussel Mytilus galloprovincialis 
Algal toxins can be accumulated by filter feeding molluscs, such as mussels. Therefore, an 
important task for comprehending the possible ecological impact of algal toxins is the assessment of 
their effects on those marine organisms. Unfortunately, while several articles report on the isolation of 
YTX from mussels of different origin [33–35], a very limited number of studies is available on the 
possible effects of YTX on mussel biology. Immunocytochemical experiments have evidenced that the 
mussel  M. galloprovincialis accumulates YTX into the cytoplasm of circulating immunocytes 
(hemocytes endowed with phagocytic activity and several immune-related functions) and the tubules 
and ducts of the digestive gland [36]. Mussels can accumulate YTX without displaying apparent 
damage, and it has been suggested that this could be due to metabolic processes that would reduce its 
toxicity [37]. We have investigated the direct effects of the toxin on mussel immunocytes. Our 
observations indicate that the toxin alone is not able to influence a fundamental activity of Mar. Drugs 2010, 8                                          
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immunocytes, i.e., cell motility. However, when the immunocytes were co-stimulated with bacterial 
extracts, the effects of the toxin were clearly observable [38]. Further experiments revealed that the 
effects of YTX on immunocytes is imputable to an augmented concentration of cytosolic Ca
2+ [32] as 
has also been suggested for human lymphocytes [31]. Furthermore, the link between YTX and immune 
functions has also been very recently confirmed in mammalian J774 phagocytes [26]. Intriguingly, the 
effects of YTX on J774 cells included an increased expression of cytokines [26], suggesting that 
possible effects of the toxin might include/determine an altered pattern of expression in immune-
related genes. 
2.4. Data derived from experiments on Swiss CD1 mice  
In spite of the increasing number of studies from different models focusing on the cellular activities 
affected by YTX, in vivo analysis performed on mice revealed conflicting toxicity data, and the 
discrepancies have been attributed to experimental laboratory conditions and the use of mice of 
different age, strain and gender [39]. The histopathological results on the target organs are not 
exhaustive and, in particular, little attention has been paid to pathological changes induced by algal 
toxin treatment in some systems i.e., lymphoid tissue. 
The effects of intraperitoneal injection of a lethal dose (420 μg/kg, causing death after less than 2 h) 
and a 24 h sub-lethal dose (10 μg/kg) of YTX have been studied in the brain, duodenum and thymus of 
male Swiss CD1 mice [22,40]. The cerebellum was demonstrated to be the most sensitive area of the 
brain, and severe morpho-functional changes were found in the Purkinje cell layer of the cortex. 
Indeed, after toxin treatment, these cells were irregularly distributed and showed an altered structure, 
with Nissl body shrinkage, nuclear chromatin condensation and significant changes in 
immunoreactivity to calcium-binding proteins and cytoskeletal components. With respect to controls, 
positivity was found to increase for the S100 protein, to decrease for calbindin D-28K (Figure 3), 
while the neuronal microtubule and neurofilament pattern organization appeared altered with a 
decreased immunoreactivity to β-tubulin (Figure 3) and neurofilament antibodies. In contrast, YTX 
did not induce any significant morpho-functional modifications in other brain regions i.e., cerebral 
cortex [22,40]. 
The duodenum was more sensitive to the higher YTX dose. In spite of the preserved general 
organization, a higher number of blood cells infiltrated between epithelial cells of villi and some blood 
cells, mainly lymphocytes, present in mucosa connective and epithelial tissue and in lymphoid Payer’s 
patches displayed apoptotic phenotypes. A larger number of cells, mostly granulocytes and 
macrophages, in the epithelial layer and underlying connective tissue were strongly immunoreactive 
for IL-6 and TNF-α while the number of cells positive to the anti-IL-8 antibody decreased. The sub-
lethal YTX dose did not induce evident histological changes, and cytokine responses also showed a 
similar trend [40]. 
In contrast to the duodenum, the thymus reacted to both YTX doses, but the structural damage was 
more severe at the sub-lethal concentration. After injecting mice with the lethal dose of 420 g/kg YTX, 
less compact areas with a reduced number of thymocytes were present in thymus cortex. Moreover, 
apoptotic phenotypes, mostly of thymocytes, increased significantly in the thymic medulla in 
particular, while mitosis activity was more stimulated in the cortex. The sub-lethal YTX dose induced Mar. Drugs 2010, 8                                          
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mainly cortico-medullary junction and medulla responses, with a significantly higher number of 
apoptotic cells than in control samples or following the lethal treatment (Figure 4).  
Figure 3. Immunolocalization of Ca
2+-binding proteins and cytoskeleton components in 
the cerebellum cortex from control (A, C) and 420 μg/kg YTX injected mice (B, D). In 
treated samples, the positivity to anti-calbindin D-28K mAb (A, B) and to anti-β-tubulin 
(C, D) decrease. Bar = 10 μm. (Reprinted with permission, modified from [22]). 
 
Figure 4. Number of apoptotic cells recorded in thymic sections from control, 420 and  
10  μg/kg YTX injected mice (*, ** p < 0.05 versus control; ** p < 0.05 versus *). 
(Reprinted with permission from [40]). 
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The mitosis was comparable to that observed at the higher dose. Round structures resembling 
Hassall’s corpuscles containing heterogeneous secretory material, cell debris and necrotic nuclei and 
dendritic cells with cytological features of active phagocytic cells were also observed in medulla. After 
YTX treatment, the most damaged cell population appeared to be the epithelial cells that were found to 
loose their reticular organization, to change cell morphology from a stellate to a round form and 
immunoreactivity to different molecular weight (MW) cytokeratins (Figure 5). The newly formed 
medullary Hassall’s corpuscle-like bodies were also immunoreactive to higher MW cytokeratins. With 
regard to cytokine response, changes in comparison to controls were observed with both YTX 
concentrations. More cells, mostly dendritic cells in cortico-medullary junction and medulla, were 
immunoreactive to IL-6, while a lower number of IL-1 and IL-8 immunoreactive cells were seen in the 
cortex [40]. 
Figure 5. Sections of thymus from control (A) and 10 μg/kg YTX injected mice (B) 
immunostained with anti-cytokeratin 1/5/10/14 mAb. Note the changes in organization of 
the medullary epithelial compartment with modifications in cell morphology and 
cytokeratin immunoreactivity. Bar = 10 μm. (Reprinted with permission, modified   
from [40]). 
 
 
On the whole, our findings suggest that the thymus and, in general, the immune system are the main 
targets of YTX at both the concentrations used, while alterations to the cerebellum are detected only at 
the lethal dose. Early indicators of the neurological disorders induced by acute YTX toxicity may be 
considered modifications of cytoskeletal components and of intracellular Ca
2+-binding protein levels 
observed in Purkinje cells. The morpho-functional changes induced in the thymus are compatible with 
those reported in thymic tumours [41–44] supporting the thesis of possible tumorigenic implications 
for this toxin. 
3. Okadaic Acid (OA) and Palytoxin (PTX)  
3.1. General proprieties 
Okadaic acid (OA) is a lipophilic compound produced by several marine dinoflagellates belonging 
to the genera Dinophysis and Prorocentrum. It is almost exclusively accumulated in mussel digestive 
gland and the consumption of these animals provokes a syndrome in humans known as DSP, 
characterized by severe gastrointestinal symptoms [45,46]. OA acts by inhibiting serine/threonine Mar. Drugs 2010, 8                                          
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protein phosphatases (PP1 and specially PP2A, [47]) that results in the hyperphosphorylation of many 
cell proteins and the dis-regulation of a variety of cellular processes. In vivo studies in mice have 
reported the distribution and excretion of OA following oral administration, as well as   
morpho-functional changes of organs targeted by the toxin. OA is primarily considered an enterotoxin 
[16,48–50], and low oral doses are also able to provoke both immunostimulation and systemic 
immunotoxicity in Swiss CD1 mice [51]. The extent of the OA-induced injuries and the toxin 
organotrophicity are dose-related [16] and may be determined by the administration route. After 
intravenous administration, OA acts as a hepatotoxin with undetectable effects on the intestine, but 
also has an impact on cytoskeletal elements at sub-lethal doses [52]. Moreover, the toxin is known to 
act as a potent neurotoxin for cultured neurons [53], to induce apoptotic events in various cell lines 
[54,55] and to exert tumor promoting activity in various organs [56–58].  
Palytoxin (PTX) is a large, water soluble polyalcohol first isolated from the soft coral of the genus 
Palythoa [59], subsequently found in a variety of marine organisms ranging from dinoflagellates to 
fish and implicated in seafood poisoning with potential danger to public health. Toxicological studies 
have shown its toxicity through different exposure routes and with different lethal exposure 
concentrations in various animal models, as summarized by Deeds and Schwartz [60]. Various 
symptoms have been described in relation to the PTX exposure route, and rhabdomyolysis, a syndrome 
involving skeletal muscle injury provoked by sarcolemma disruption, is a complication of the 
poisoning [61–63]. Acute oral administration in mice induced histological and ultrastructural changes 
in several organs, such as liver, pancreas, cardiac and skeletal muscle cells [64]. The toxin is known to 
affect cellular functions by selective binding to the membrane Na
+-K
+ ATPase, which is essential in 
maintaining ionic gradients, and converting the pump into a non-selective channel [65,66]. The 
induced ion flux alterations are reported to target pathways involved in cytoskeletal dynamics within 
different cellular models [12]. Additionally, PTX has been identified as a potent tumor promoter which 
modulates MAP protein kinase cascades by different mechanisms [11]. 
3.2. Data derived from experiments on invertebrate models 
The effects of OA have been studied on the structural organization of the potworm Enchytraeus 
crypticus, an annelid species widely used in ecotoxicological laboratories to test the effects of 
chemical stress [67]. This experimental model proved very sensitive to OA treatment (added to food) 
in a time- and dose-related manner [68]. After 48 h of treatment at the lower dose (100 nM), the main 
organs were not particularly affected, except for a swelling of the celomatic cavity and the number of 
circulating celomocytes. Conversely, at 400 nM OA, a general cell suffering was observed in the 
animal’s main organs. After 12 h, and to a greater extent after 48 h, of treatment with an intermediate 
OA concentration (200 nM), the structural organization of the chloragogenous tissue, a layer of cells 
that separate the “blood” from the celomic fluid [69], appeared modified (Figure 6), and an immune 
response involving a higher number of circulating celomocytes immunoreactive to anti-IL-6 antibody 
was observed (Figure 6).  
The nervous system, in particular the ventral nerve cord, was also affected, presenting fewer IL-6 
immunoreactive cells [68]. The ability of E. crypticus of different ages samples (25 days and three 
months) to restore the induced toxicological injuries was also analyzed, and the results indicated that Mar. Drugs 2010, 8                                          
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the older worms were more sensitive to the toxin, with the capacity to recover lower than that found in 
specimens aged 25 days. First signs of restoration from the morpho-functional modifications were seen 
in younger worms at 48 h, with an almost complete recovery within one week. In older animals, the 
morphology of the chloragogenous tissue was not restored, while a reduction in celomocyte number 
was found after one week [70]. 
Figure 6. Longitudinal sections from E. crypticus controls (A, C) and specimens treated 
with 100 nM OA for 24 h (D) and 200 nM OA for 12 h (B) stained with gallocyanin-
chrome alum (A), Mallory-Azan stain (B) and immunostained with anti-IL-6 polyclonal 
antibody (C, D). (A) The chloragogenous tissue (c) from controls formed one or two layers 
of round vacuolated and basophilic cells surrounding the intestine (i). (B) After OA 
treatment, the tissue showed a higher number of cell layers and expanded into the 
celomatic cavity. The toxin also induced an increase in the number of circulating 
celomocytes. (C, D) Immunonegative chloragocytic cells, arrows; immunopositive 
amoebocytes, arrowheads. Bar = 10 μm. (Reprinted with permission, modified from [68]). 
 
 
As mentioned above for YTX, the analysis of biological effects of toxins on those animals that 
naturally accumulate them [71] still remains a relatively unexplored field. The effects of OA and PTX 
on the phagocytic activity of mussel immunocytes, have been tested both in normal conditions and 
after exposure to possible stressful situations [72]. Our data indicate that OA effects strictly depend on 
the incubation temperature [72]. Indeed, only when the immunocytes were exposed to the toxin at the 
temperature of 25 °C was it possible to observe a significant increase in the percentage of 
phagocytizing immunocytes. At the temperature of 20 °C, OA appeared to have no effect on the Mar. Drugs 2010, 8                                          
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phagocytic activity of molluscan immunocytes [72]. PTX augmented the percentage of phagocytizing 
cells independently of the temperature. Unlike YTX and OA, PTX also seems to intervene actively in 
the signaling pathway of mussel immunocytes, since increased immunoreactivity towards the 
phosphorylated form of the p38 MAP kinase was observed through immunoblot experiments. 
Moreover, the effects of PTX on immunocytes were annulled by the p38 MAP kinase inhibitor SB 
203580 [72]. Since in M. galloprovincialis immunocytes, the signaling pathway involving p38 MAP 
kinase can be differentially regulated in the presence of mild stress [73], the effects of PTX, which also 
rely on that pathway, may vary on the basis on mussel conditions. Altogether, the data collected in  
M. galloprovincialis indicate that the neutrality displayed by the accumulated toxins may just be 
apparent, since toxin effects can change when the biochemical milieu inside the cells changes as a 
consequence of environmental modifications. 
3.3. Data derived from experiments on the amphibian X. laevis 
FETAX protocol has been widely described and applied to different substances [74–79], and it is a 
powerful and flexible bioassay for developmental toxicants that makes use of the embryos of the 
anuran X. laevis. In embryos, this biological assay can verify the effects of a toxicant in terms of 
mortality, delayed growth and embryo malformation. The test has numerous advantages: the use of a 
non-mammalian species, X. laevis, that is easy to maintain and can be bred throughout the year; the 
assay can be carried out in a short time and with relatively low costs; the method guarantees a good 
repeatability of results and provides a large amount of data for statistical analysis. The assay has been 
widely described and applied for various substances [74–79] and has been recently utilized, together 
with further histological and molecular investigations, to investigate the effects of OA and PTX on 
vertebrate development [80–82].  
X. laevis embryos at early gastrula stage (stage 10 [83]) were treated with different concentration of 
OA (0.1, 1 and 10 nM) for five days. Deceased and malformed embryos were counted daily, and at the 
end of the test the percentage of treated embryos showing delayed growth was evaluated by measuring 
head-tail length [80]. The morpho-functional modifications of surviving young larvae   
(stage 47) were also studied. The bioassay showed that OA affects the above parameters in a dose-
correlated manner (Figure 7, [80]). Morphological observations of treated samples revealed a marked 
folding of the tail (Figure 8) that caused severe histological and histochemical damage to the nervous 
system (the most sensitive tissue) and to the tail skeletal musculature, while modifications also 
involved the intestine, liver and kidney. Indeed the rhombencephalon and spinal cord appeared 
reduced in size with irregularly arranged neuron cell bodies. The apoptotic figures counted in the 
rhombencephalon significantly increased compared to controls. Smaller, fewer and irregularly 
distributed muscle fibers, sometimes detaching at the periphery, were found in tail skeletal 
musculature. Depending on the extent of tail folding, there was a compression and/or reduction of the 
abdominal cavity with altered macroscopic and microscopic arrangements of the inner organs [80]. 
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Figure 7. FETAX bioassay: time- and concentration-dependent effects of OA on embryo 
mortality (*p < 0.05 versus control). (Reprinted with permission from [80]). 
 
Figure 8. Images of control (A) and 1 nM OA treated (B) X. laevis early larval stages: note 
the tail folding and the reduced size at the end of toxin treatment. Bar = 1 mm. (Reprinted 
with permission from [80]). 
 
 
The toxicological effects of PTX evaluated by FETAX assay revealed evident impacts on embryo 
mortality, teratogenesis and growth at two toxin concentrations (370 and 37 nM) [81]. Significant 
mortality rates (Figure 9), peaks in malformed embryo number and delays in growth were found, and 
the initial sample population fell by about 80% at the end of the assay when using the higher   
dose (Figure 10).  
The histological analysis of the surviving young larvae (stage 47) revealed structural changes 
compared with controls in the nervous and muscle tissue, even if some specimens did not show any 
significant histopathological modifications. A general reduction in the size of the main inner visceral 
organs (i.e., intestine, pancreas and liver) was seen, but no morphological changes. Severe injury to the 
heart structure was observed in some specimens. No inflammatory response was observed [81]. 
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Figure 9. FETAX bioassay: time- and concentration- dependent effects of PTX on sample 
mortality (*p < 0.05 versus control). (Reprinted with permission from [81]). 
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Figure 10. FETAX bioassay: percentage of dead samples compared to the initial embryo 
number (*p < 0.05 versus control). (Reprinted with permission from [81])  
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On the basis of FETAX and histological results, molecular biology based experiments were also 
performed to assess more precisely the target of OA and PTX [82]. In particular, four genes involved 
in the early events of X. laevis development (specifically, neural and muscular specification and 
patterning), i.e., siamois, engrailed-2, bone morphogenetic protein 4 (bmp4), and myogenic factor 5 
(myf5) [84–90], were tested.  
X. laevis embryos at early gastrula (stage 10 [83]) were treated with 10 nM OA [80] or 370 nM 
PTX, [81] and RT-PCR analyses were performed at the following stages of embryonic and post-
embryonic development after different toxin exposure times: about 3 h (stage 11), 5 h (stage 12), 8 h 
(stage 14), 10 h (stage 17), 1 d (stage 26), 2 d (stage 35), 3 d (stage 41), 4 d (stage 45), 5 d (stage 47). 
Both toxins induced an over-expression of siamois and engrailed-2. Siamois was only found in the 
tested gastrulation stages (11 and 12). Engrailed-2 expression levels were first detected at stages 14, 
increased at stage 26 and did not differ significantly from the controls at further development   
(stages 35–47). Different behavior was seen for bmp4 and myf5 (Figures 11, 12). Indeed, OA provoked Mar. Drugs 2010, 8                                          
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a significant increase in bmp4 in the earliest stage examined, a down-regulation from stages 12-17, and 
a renewed increase from the beginning of hatching onwards (stages 35–47). In contrast, myf5 was  
up-regulated in all stages up to 35. PTX induced an over-expression of both bmp4 and myf5 during the 
embryonic and early larval development stages. 
Figure 11. bmp4 expression levels in X. laevis embryonic and early larval stages after 
toxin treatments. Bars represent standard deviation (SD) from the mean value of light 
intensity registered for each sample and normalized versus control value (*p < 0.05). 
(Reprinted with permission from [82]). 
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Figure 12. myf5 expression levels in X. laevis embryonic and early larval stages after toxin 
treatments. Bars represent SD from the mean value of light intensity registered for each 
sample and normalized versus control value (*p < 0.05). (Reprinted with permission   
from [82]).  
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The results show that PTX induces an increase in expression levels in all tested genes, while the 
response to OA seems to be more stage-dependent, with the embryonic development stages more 
sensitive to the toxin than the larval stages [82]. More importantly, even though these processes 
deserve further studies, both OA and PTX seems able to interfere with gene expression, as it has 
recently been proposed also for YTX [26].  
4. Conclusions  
The general label of marine algal toxins combines very diverse molecules presenting different 
targets and specific modes of action. These toxins are currently studied in numerous models and 
reports of conflicting data are therefore not surprising. In this sense, the experiments performed in 
mussels are a good example of different outcomes dependent on experimental and animal conditions. 
Several researchers have concentrated their attention on the molecular structure, targets and 
toxicological properties of marine toxins. From our and other laboratory findings, the cytoskeleton, a 
structure finely integrated to cell functions, appears to be particularly susceptible to the mechanisms 
induced by the different toxins. However, the large number of organs and functions targeted by toxins 
such as YTX, OA and PTX should also prompt the adoption of new protocols, e.g., FETAX assay and 
molecular biology-based strategies, in order to study the influence that these toxins may exert on 
widely complex biological processes including, for instance, development. 
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